SCYNEXIS Reports Second Quarter 2020 Financial Results and Provides Company Update

NEXT STORY
Turning Point Therapeutics Reports Second-Quarter Financial Results, Provides Operational Updates
PREV STORY
Adaptive Biotechnologies to Present at the UBS Genomics 2.0 and Medtech Innovations Summit
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Asterias Provides Six Month Data Readout for its AST-OPC1 Phase 1/2a Clinical Trial in Severe Spinal Cord Injury

- Current Readout Includes New Six Month Data for Cohort 5 and Aggregate Trial Data ...

author_avatar
NASDAQ Market News

Kura Oncology Added to Nasdaq Biotechnology Index

SAN DIEGO, Dec. 18, 2017 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq:KURA), a clinical-stage ...

author_avatar
NASDAQ Market News

Myriad Genetics Reports Fiscal First-Quarter 2019 Financial Results

Total First-Quarter Revenues of $202.3 Million, Up 13 PercentFirst-Quarter Diluted EPS of ($0.01) and ...

author_avatar
NASDAQ Market News